Loredana Puca, Ph.D, is a postdoctoral research fellow in our lab. Her research focus is on identifying new biomarkers and therapies to prevent or treat a very aggressive subtype of prostate cancer called neuroendocrine prostate cancer (NEPC) using 3D human organoids, which are cultures derived from metastatic prostate cancer patients. She received her PhD from the Institut Pasteur, Paris (France), and her MS from the University of Naples “Federico II” (Italy).